25-27 February, 2019
London, UK
250+Attendees ♦ 40 World Class Speakers   33+ Case Studies ♦ 2 Tracks  6 Deep Dive Discussion Sessions 

Content Library

CART0TCR - EU presentation

How to Generate Optimal-Affinity TCRs for the Clinic?

By Elisa Kieback, CEO, T-Knife


Development of First Manufacturing Process to Produce CAR-Treg Cells for Clinical Use

By Pierre Heimendinger, VP Pharmaceutical Development, TxCell


Regenerative Medicines and Cell Therapy Products: Is the NICE Therapy Products: Is the NICE Therapy

By Grace Hampson, Senior Economist, The Office of Health Economics